Navigation Links
AHRQ Releases Two New Resources to Help Consumers and Clinicians Prevent Dangerous Blood Clots
Date:9/15/2008

ROCKVILLE, Md., Sept. 15 /PRNewswire-USNewswire/ -- Two new guides to help consumers and clinicians prevent and treat deep vein thrombosis were released today by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality.

Not all blood clots are harmful but deep vein thrombosis, a blood clot that forms in the deep veins of the body, most commonly in the lower leg or thigh, is a potentially deadly medical problem that affects at least 350,000 and possibly as many as 600,000 Americans each year, according to The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism that was also released today. AHRQ's resources are independent of the Call to Action.

AHRQ's consumer booklet, Your Guide to Preventing and Treating Blood Clots, is a 12-page easy-to-read resource that helps both patients and their families identify the causes and symptoms of dangerous blood clots, learn tips on how to prevent them and know what to expect during treatment.

The clinician guide, Preventing Hospital-Acquired Venous Thromboembolism: A Guide for Effective Quality Improvement, is a comprehensive tool to help hospitals and clinicians implement processes to prevent dangerous blood clots. The 60-page guide details how to start, implement, evaluate and sustain a quality improvement strategy. It includes case studies, as well as examples of forms that clinicians in the field can use.

"Blood clots can be a serious condition affecting hundreds of thousands of Americans each year," said AHRQ Director Carolyn M. Clancy, M.D. "We know how to prevent many of these dangerous blood clots, and these guides will help patients and clinicians put that knowledge to work to improve care."

Dangerous blood clots can form when a person is stationary for a long period of time, such as when recovering from surgery, being hospitalized or traveling long distances. A blood clot that travels to the lung is called a pulmonary embolism.

"These timely, easy-to-read guides provide valuable information on preventing and treating dangerous blood clots," said Acting Surgeon General Steven K. Galson, M.D., M.P.H. "They are also valuable tools for health care providers to use with their patients who are at risk for dangerous blood clots."

The AHRQ guides were developed from toolkits originally created by experts funded through AHRQ's Partnerships in Implementing Patient Safety grant program (http://www.ahrq.gov/qual/pips). The consumer guide, Your Guide to Preventing and Treating Blood Clots, is based on work by Brenda Zierler, Ph.D., R.N. at the University of Washington, Seattle. It is available in both English (http://www.ahrq.gov/consumer/bloodclots.htm) and Spanish (http://www.ahrq.gov/consumer/spblclots.htm). The clinician guide, Preventing Hospital-Acquired Venous Thromboembolism: A Guide for Effective Quality Improvement (http://www.ahrq.gov/qual/vtguide), reflects the work of Gregory Maynard, M.D., at the University of California, San Diego, with contributions from Jason Stein, M.D., at Emory University in Atlanta.

Treatment for blood clots often includes blood thinning medications such as Coumadin(R) (generic name: warfarin). AHRQ recently published Your Guide to Coumadin(R)/Warfarin Therapy (http://www.ahrq.gov/consumer/coumadin.htm) to help these patients better understand their treatment. This guide also originated from an AHRQ-funded patient safety project and is based on the work of James Levett, M.D. and Carla Huber, A.R.N.P., M.S., at Kirkwood Community College in Cedar Rapids, Iowa.

Free, single copies of all AHRQ publications are available by calling the AHRQ Publications Clearinghouse at (800) 358-9295 or by sending an e-mail to AHRQPubs@ahrq.hhs.gov.


'/>"/>
SOURCE Agency for Healthcare Research & Quality
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sodexo Releases Innovative Prepaid Incentive Card Powered by eCommLink
2. Z Trim Holdings, Inc. Releases Letter to Shareholders
3. Mindray Releases Historical Financial Results Converted into US Dollar Terms
4. Pennsylvania Trauma Systems Foundation Releases Data Supporting Mandatory Use of Motorcycle Helmets
5. URAC Releases Revised Standards For Nine Health Care Management Accreditation Programs
6. ABC Releases Monograph on Scientific Research of POM Wonderful(R) Pomegranate Juice
7. ProSanos Corporation Releases New Software System to Improve Patient Safety via Surveillance and Analysis of Claims and Electronic Health Records
8. Wellcorps International Releases Breakthrough Multi-Benefit WellCapAM(TM) Activation Complex
9. Providence Service Corporation Releases Second Quarter Results
10. As AIDS Conference Opens, amfAR Releases Report Exposing Global Failure to Address HIV Among MSM
11. The Latino Commission on AIDS Releases Report on the State of HIV/AIDS in Latino/Hispanic Communities in the United States on the Eve of the International AIDS Conference in Mexico City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , ... partnership with Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South ... care plan incentives to a patient’s remote health progress, empowering the patient to take ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be ... conditions and has helped many women become pregnant upon treating their diagnosis. ... and simple outpatient evaluations. We can provide the necessary information to diagnose ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn more about ... ) that demonstrates how this advanced plant breeding technology is a more efficient ... fewer resources. It highlights the business’ principles, research and collaboration efforts in this ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... is proud to announce that it has received 510(k) clearance from the U.S. ... Home and the MyoCycle Pro. , Both devices are stationary cycling systems that ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... have signed an agreement to be the preferred physical therapy provider for Derby ... returning them to Derby City CrossFit as quickly and effectively as possible, ProRehab’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology: